Privatization of the Central Medical Supplies (CMS) Public Corporation: A Study

Gamal K. M. Ali

Department of Pharmaceutical Services and Planning Manager, Federal Ministry of Health, Khartoum, Sudan

Abdeen Mustafa Omer *

Occupational Health Administration, Ministry of Health, Khartoum, Sudan and UON, Forest Road West, Nottingham NG7 4EU, United Kingdom.

*Author to whom correspondence should be addressed.


Abstract

To improve the effectiveness of the public pharmacy, resources should be switched towards areas of need for reducing inequalities and promoting better health conditions. Medicines are financed either through cost sharing or full private. The role of the private services is significant. A review of reform of financing medicines in Sudan is given in this article. Also, it highlights the current drug supply system in the public sector, which is currently responsibility of the Central Medical Supplies Public Corporation (CMS). In Sudan, the researchers did not identify any rigorous evaluations or quantitative studies about the impact of drug regulations on the quality of medicines and how to protect public health against counterfeit or low quality medicines, although it is practically possible. However, the regulations must be continually evaluated to ensure the public health is protected by marketing high quality medicines rather than commercial interests, and the drug companies are held accountable for their conducts.

Keywords: Sudan, quality of medicines, drug importers, regulatory authorities, counterfeits medicines


How to Cite

Ali, Gamal K. M., and Abdeen Mustafa Omer. 2011. “Privatization of the Central Medical Supplies (CMS) Public Corporation: A Study”. Journal of Economics, Management and Trade 1 (1):21-32. https://www.journaljemt.com/index.php/JEMT/article/view/343.

Downloads

Download data is not yet available.